Table 2.
Examples of tick saliva molecules with immunomodulatory functions.
| Category | Molecule | Function |
|---|---|---|
| Inhibition of T-cell activity | Salp15 | Interferes with T cell receptor (TCR) signaling, IL-2 production, activation of CD4+ T cells by dendritic cells (117, 128). |
| Sialostatin L | Inhibits cathepsin L, reducing antigen presentation and T cell activation (143). Inhibits production of IL-9 in mast cells and maturation of dendritic cells | |
| Complement Inhibition | Salp20 | Inhibits the alternative complement pathway, protecting pathogens from complement attack (58). |
| ISAC | Negative regulator of alternative complement activation (104). | |
| IRAC I and II | Negative regulator of alternative complement activation (105). | |
| Anti-inflammatory function | Histamine-binding proteins (HBP) | Neutralize histamine to suppress local inflammation (144). |
| Prostaglandin E2 | Modulates inflammatory responses and promotes vasodilaton (92). Inhibits T cell activation. | |
| Sialostatin L2 | Reduces pro-inflammatory cytokine production (e.g., TNF-α, IL-12) by targeting cathepsins (143). Inhibits NLRC4-mediated inflammasome activation. | |
| Anti-coagulant | Ixolaris | Inhibits thrombin generation and blood coagulation, supporting efficient blood-feeding (145). |
| Serpins | Serin protease inhibitors regulating angiogenesis, inflammation, and tissue remodeling (146). | |
| Immune cell recruitment | Tick salivary lectin pathway inhibitor (TSLP) | Impairs neutrophil phagocytosis and chemotaxis (64). |
| Apyrase | Hydrolyzes ATP and ADP, inhibiting neutrophil activation and platelet aggregation (147). | |
| Evasins | Bind and neutralize host chemokines, effectively suppressing immune cell recruitment (98). |